Oppenheimer & Co. Inc. Trims Stake in Amprius Technologies, Inc. $AMPX

Oppenheimer & Co. Inc. lessened its stake in shares of Amprius Technologies, Inc. (NYSE:AMPX) by 33.4% during the third quarter, Holdings Channel.com reports. The institutional investor owned 299,339 shares of the company’s stock after selling 149,858 shares during the period. Oppenheimer & Co. Inc.’s holdings in Amprius Technologies were worth $3,149,000 at the end of the most recent reporting period.

Other institutional investors also recently made changes to their positions in the company. Bank of America Corp DE lifted its position in shares of Amprius Technologies by 31.1% in the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock valued at $36,000 after acquiring an additional 3,055 shares in the last quarter. Ameritas Investment Partners Inc. raised its stake in Amprius Technologies by 2,043.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock valued at $40,000 after purchasing an additional 9,072 shares during the last quarter. Rhumbline Advisers lifted its holdings in Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after purchasing an additional 5,951 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of Amprius Technologies by 1,385.4% during the 2nd quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock worth $44,000 after purchasing an additional 9,684 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of Amprius Technologies during the second quarter worth about $44,000. 5.04% of the stock is owned by institutional investors and hedge funds.

Amprius Technologies Stock Down 8.5%

Shares of AMPX opened at $10.17 on Friday. Amprius Technologies, Inc. has a fifty-two week low of $1.70 and a fifty-two week high of $16.03. The company’s fifty day moving average is $10.45 and its two-hundred day moving average is $10.27. The firm has a market cap of $1.33 billion, a PE ratio of -39.12 and a beta of 2.99.

Insiders Place Their Bets

In other Amprius Technologies news, CEO Kang Sun sold 1,000,000 shares of the business’s stock in a transaction dated Monday, November 17th. The stock was sold at an average price of $10.60, for a total transaction of $10,600,000.00. Following the completion of the sale, the chief executive officer owned 1,472,306 shares of the company’s stock, valued at approximately $15,606,443.60. The trade was a 40.45% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Constantin Ionel Stefan sold 492,827 shares of the company’s stock in a transaction dated Thursday, January 22nd. The stock was sold at an average price of $12.04, for a total value of $5,933,637.08. Following the sale, the chief technology officer owned 748,696 shares of the company’s stock, valued at $9,014,299.84. This represents a 39.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 3,399,331 shares of company stock worth $37,048,615 in the last quarter. 12.90% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Needham & Company LLC started coverage on shares of Amprius Technologies in a research note on Thursday, January 29th. They set a “buy” rating and a $20.00 price objective on the stock. Oppenheimer reiterated an “outperform” rating and issued a $17.00 price target on shares of Amprius Technologies in a report on Tuesday, December 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of Amprius Technologies in a report on Wednesday, January 21st. Roth Mkm set a $14.00 target price on Amprius Technologies and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Finally, Cantor Fitzgerald increased their target price on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Seven investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $16.57.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.